Information  X 
Enter a valid email address

Amryt Pharma PLC Ord 6P Ord Ne (AMYT)

Date Time Source Announcement
19 Oct 2020 7:00 am
GNW
Amryt and Swixx Sign Distribution Deal for Lojuxta
14 Oct 2020 7:00 am
RNS
AMRYT TO ANNOUNCE Q3 RESULTS ON NOVEMBER 5, 2020
  7:00 am
GNW
Notice of Results
12 Oct 2020 11:00 am
GNW
Holding(s) in Company
09 Oct 2020 7:00 am
GNW
Virtual Analyst & Investor Event - Tuesday November 3, 2020
08 Oct 2020 7:00 am
GNW
AMRYT TO PRESENT EASE TRIAL DATA BY LATE-BREAKING PRESENTATION AT EADV ON OCTOBER 31, 2020
01 Oct 2020 7:00 am
GNW
Exercise of Options and Total Voting Rights
30 Sep 2020 12:30 pm
GNW
Holding(s) in Company
23 Sep 2020 7:00 am
RNS
AMRYT SUPPORTS GLOBAL FH AWARENESS DAY
21 Sep 2020 11:00 am
GNW
Exercise of Warrants & Issue of Ordinary Shares and Total Voting Rights
15 Sep 2020 7:00 am
RNS
POSITIVE OPINION ON AP103 ORPHAN DRUG DESIGNATION
09 Sep 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
POSITIVE TOP LINE RESULTS FROM PHASE 3 TRIAL IN EB
11 Aug 2020 11:09 am
RNS
CANCELLATION OF ADMISSION TO EURONEXT GROWTH
07 Aug 2020 7:00 am
RNS
AMRYT PRESENTING AT CANACCORD GENUITY CONFERENCE
06 Aug 2020 12:00 pm
RNS
AMRYT ANNOUNCES Q2 2020 RESULTS
29 Jul 2020 2:30 pm
RNS
Result of AGM
  7:00 am
RNS
AMRYT HOSTING KOL CALL ON EB DISEASE LANDSCAPE
20 Jul 2020 7:00 am
RNS
AMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020
15 Jul 2020 8:00 am
RNS
Euronext Growth Dublin Notice
10 Jul 2020 7:00 am
RNS
Exercise of Warrants & Issue of Ordinary Shares
08 Jul 2020 3:09 pm
RNS
AMRYT LISTED ON NASDAQ & CEO TO RING CLOSING BELL
30 Jun 2020 7:00 am
RNS
POSTING OF ANNUAL REPORT AND NOTICE OF AGM
24 Jun 2020 7:00 am
RNS
Form F-1 publicly filed for impending US listing
04 Jun 2020 2:20 pm
RNS
Director/PDMR Shareholding
03 Jun 2020 11:30 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
AMRYT & SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA
11 May 2020 7:00 am
RNS
Q1 2020 RESULTS
  7:00 am
RNS
FY 2019 RESULTS
07 May 2020 9:00 am
RNS
Notice of Results
  7:00 am
RNS
FILSUVEZ? CONFIRMED AS GLOBAL BRAND NAME FOR AP101
23 Apr 2020 7:00 am
RNS
EASE CLINICAL STUDY UPDATE
25 Mar 2020 7:00 am
RNS
Holding(s) in Company
23 Mar 2020 7:00 am
RNS
Market Update
19 Feb 2020 12:00 pm
RNS
Draft registration statement for US Nasdaq listing
15 Jan 2020 5:16 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Amryt to present updates from its EB research
07 Jan 2020 12:09 pm
RNS
PDMR Dealings
30 Dec 2019 11:07 am
RNS
Holding(s) in Company
27 Dec 2019 8:00 am
RNS
Euronext Growth Dublin Notice
23 Dec 2019 11:22 am
RNS
Holding(s) in Company
20 Dec 2019 2:40 pm
RNS
Exercise of Warrants & Issue of Ordinary Shares
19 Dec 2019 7:00 am
RNS
Business integration and synergies on track
26 Nov 2019 7:00 am
RNS
Holdings in Company
18 Nov 2019 7:00 am
RNS
Holdings in Company
14 Nov 2019 4:31 pm
RNS
Share Buyback
05 Nov 2019 6:16 pm
RNS
Grant of Options
  7:00 am
RNS
Trading Update
04 Nov 2019 7:00 am
RNS
Notice of Trading Update
28 Oct 2019 4:58 pm
RNS
Holding(s) in Company
03 Oct 2019 4:38 pm
RNS
Holdings in Company
01 Oct 2019 7:00 am
RNS
AP101 Receives Fast Track Designation from FDA
30 Sep 2019 4:30 pm
RNS
Half-year Report
  7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Investor Events Update
25 Sep 2019 8:00 am
RNS
Euronext Growth Dublin Notice
  7:00 am
RNS
Completion of Acquisition and $60m equity raised
  7:00 am
RNS
Euronext Growth Dublin Cancellation Notice
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t